Satiety · Article
Food Noise: What It Is, What the Science Says and What GLP-1 Drugs Do
What food noise is, how researchers define and measure it, what Wegovy, Zepbound, Ozempic and Mounjaro do to it, what happens when you stop, and when it's something more.
- Written by
- Alex Gonzalez
- Published
- Next review
- Sources
- 13 primary and 8 supporting
No clinical review. No advertising from drug companies and no affiliate links.How we work
“Food noise” is the popular name for thoughts about food that won’t switch off: what you’ll eat, when, whether you should, and around again. It isn’t a diagnosis. According to a 2023 review, it’s a colloquial term that grew out of what patients and clinicians described: on GLP-1 medications, many people said the noise went quiet, something that still needed systematic study[1]. Since 2025 there are formal definitions and a validated questionnaire23, but I haven’t yet found a placebo-controlled trial that measures it with that questionnaire.
In 30 seconds
- What it is: persistent thoughts about food that the person finds unwanted or distressing and that may cause them problems, according to a 2025 definition[2].
- It’s common: in a survey of 1,000 US adults, 18% said they experience it often or always[4].
- Drugs: the US labels for Wegovy and Zepbound link lower calorie intake to appetite; the EU labels go further and mention fewer cravings891011. None uses the words “food noise”.
- When you stop: withdrawal trials measure weight, not food noise; on average, much of the weight comes back1718.
- Red flag: if it comes with binges or loss of control, it may be an eating disorder, and that’s treatable[21].
If what you feel is physical hunger, see always hungry: causes and what helps; if it’s on a GLP-1, see still hungry on Ozempic or Mounjaro. If it’s specifically sweets, see sweet cravings on GLP-1s.
What is food noise?
The phrase wasn’t born in a lab, but since 2023 it has working definitions:
| Source | How it’s defined | What it adds |
|---|---|---|
| Hayashi, 2023, narrative review | Heightened or persistent food cue reactivity that often leads to intrusive thoughts about food and unhealthy eating behaviors[1] | Links it to food cue reactivity: seeing, smelling or thinking about a food triggers the response |
| Diktas, 2025, the FNQ questionnaire | Persistent, intrusive thoughts about food that disrupt daily life and make healthy behaviors difficult[3] | Makes it measurable: 5 questions, scored 0 to 20 |
| Dhurandhar, 2025, expert panel | Persistent thoughts about food that the person perceives as unwanted or distressing and that may cause social, mental or physical problems[2] | Separates the noise from normal food thoughts: what matters is the burden, the persistence and the distress |
All three agree on the basics: it isn’t thinking about food, which is normal, but those thoughts persisting, bothering you and being hard to push aside. The 2025 panel compares it to rumination, repetitive thinking that crowds out other mental activity[2].
A note on funding: the FNQ questionnaire has four authors who are employees or shareholders of WW International (Weight Watchers)[3]. The 2025 panel was funded by the company Ro, and two of its authors report ties to Novo Nordisk or Eli Lilly[2]. That doesn’t invalidate the work, but it’s worth knowing.
Is constantly thinking about food common?
The first population figure I’ve found came in 2026. Hayashi and Masterson asked 1,000 US adults, in a sample weighted to represent the population, how often they experience “food noise”, described to them as “constantly thinking about food, even when not hungry”[4]:
- 50.9% said at least sometimes, and 18.0% often or always.
- It was more common in women (22.7% vs. 12.7% in men) and in adults under 30 (26.5%).
- The strongest link, also after adjusting for other factors, was loss of control over eating: among those who reported it, 56.8% had food noise often or always.
- It was also more common among current GLP-1 users (25.8%) than among non-users (16.3%).
It’s a single question, not a validated scale, asked at one point in time, so it can’t show what causes what. More food noise among GLP-1 users doesn’t mean the drug causes it: the authors think it more likely that the people who struggle most with it are the ones who seek or get treatment[4].
How it overlaps with what science already measured
The name is new, but it overlaps with ideas researchers have studied for years. I explain the difference between hunger, cravings and food noise in still hungry on a GLP-1; here’s how each one is measured:
| Concept | What it describes | How it’s measured |
|---|---|---|
| Hedonic hunger | Wanting to eat for pleasure rather than for energy, driven by an environment full of highly palatable food (Lowe and Butryn, 2007)[5] | Power of Food Scale (PFS): measures appetite for palatable food, not what’s eaten, when food is available, present and tasted[6] |
| Food cravings | An intense desire for a specific food | Food Cravings Questionnaire-Trait (FCQ-T): 39 items, or 15 in the short version by Meule (2014)[7] |
| Control of eating | Cravings, the ability to resist them, hunger and fullness | Control of Eating Questionnaire (CoEQ), 19 items, used in the STEP 5 trial[13] |
| Food noise | Persistent, intrusive, unwanted thoughts about food | Food Noise Questionnaire (FNQ), 5 items[3] |
The overlap is large. When the FNQ was validated in 396 adults, its score correlated at 0.87 with the preoccupation-with-food subscale of the FCQ-T and at 0.79 with a food preoccupation questionnaire[3]. A correlation of 1 would mean measuring exactly the same thing. The authors themselves acknowledge that five items may miss other aspects of the concept[3].
My take: food noise isn’t made up, but much of what’s said about it comes from studies that measured cravings, food preoccupation or control of eating under other names.
What GLP-1 drugs do to food noise
What the labels say
No label uses the words “food noise”. The closest they get is what they say about appetite and cravings, and the US and EU labels don’t say the same thing.
- Wegovy and Zepbound (US). Section 12.1 of the Wegovy label says GLP-1 is a physiological regulator of appetite and caloric intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation. Section 12.2 of both the Wegovy label and the Zepbound label says the drug decreases calorie intake, and the effects are likely mediated by affecting appetite89. The US labels don’t mention cravings.
- Wegovy (EU). The EU prescribing information says semaglutide may affect the hedonic reward system through direct and indirect effects in brain areas including the septum, thalamus and amygdala, and that in clinical studies it reduces feelings of hunger and the frequency and intensity of cravings, and reduces the preference for high-fat foods[10].
- Mounjaro (EU). The EU prescribing information for tirzepatide, the same drug as Zepbound, says it reduces the intensity of food cravings and preferences for high-sugar and high-fat foods[11].
These are average effects compared with placebo, not a promise for any one person.
What the trials measured
| Study | Who and how long | What it measured | Result |
|---|---|---|---|
| Blundell, 2017 | 30 adults with obesity; semaglutide 1 mg; 12 weeks, crossover vs. placebo | Hunger, cravings, control of eating, food preference | Less hunger and fewer cravings, better control of eating and less preference for fatty foods; 24% fewer calories across the day’s free-choice meals[12] |
| STEP 5, Wharton 2023 (summary) | 174 adults with overweight or obesity (a subgroup); semaglutide 2.4 mg; 104 weeks | 19-item CoEQ | Craving control and savory cravings improved at weeks 20, 52 and 104; sweet cravings only at weeks 20 and 52. Not adjusted for multiple comparisons[13] |
| Tronieri, 2020 | 113 adults with obesity, in a three-arm trial; liraglutide 3 mg plus behavioral therapy vs. therapy alone; 52 weeks | Food preoccupation on a 0 to 100 scale | At week 6, it fell 16.3 points with liraglutide and barely changed without it. The difference held through week 24, but not at week 52[14] |
Tronieri’s trial comes closest to the concept, and its nuance matters: by one year the difference had faded, even though the liraglutide group had lost more weight (11.8% vs. 6.2%)[14]. Liraglutide is an older GLP-1; I don’t know whether the same happens with semaglutide or tirzepatide.
The 2025 joint advisory on nutrition and GLP-1 therapy, from four US medical and nutrition societies, notes that several studies show reduced food preoccupation or “food noise”, less emotional eating and fewer binge episodes[16]. Its authors add that in practice they see many people become less interested in food and ruminate about it less[16].
The only data using the food noise questionnaire
In the INFORM survey, 550 US adults using semaglutide for weight management, 86% of them women, filled in the FNQ twice: recalling how things were before and how they are now. The median score fell from 13 to 6 out of 20[15]. But it relies on memory, has no comparison group, drew on a consumer panel and was commissioned by the manufacturer, Novo Nordisk[15]. It’s good for raising the question, not for answering it.
What happens when you stop
I haven’t found studies that measure food noise after stopping a GLP-1. Withdrawal trials measure weight:
- STEP 1 extension (summary). In the subgroup followed after the trial, people who had lost an average of 17.3% on semaglutide regained 11.6 percentage points in the year after stopping, about two-thirds of what they had lost[17].
- SURMOUNT-4 (summary). After 36 weeks on tirzepatide, those switched to placebo gained 14.0% over 52 weeks; those who continued lost another 5.5%[18].
My assumption is that if appetite and cravings return, food noise does too, but that’s my inference, not a measured result. Why appetite comes back and what’s linked to regaining less weight is in stopping a GLP-1 and weight regain. Whether and how to stop is a decision to make with your doctor.
What helps without medication (and what isn’t proven)
No study has tested any strategy against food noise measured with the FNQ. What follows are habits with some support for hunger or cravings, which make sense as a foundation.
Regular meals, no long gaps
The 2025 advisory encourages regular, small meals at consistent times and recommends minimizing long periods without meals that leave you overly hungry[16]. On a GLP-1 this matters more: the same advisory warns that low interest in food can lead people to go several hours without eating[16].
Enough sleep
In a 2004 trial with 12 healthy young men, two short nights raised hunger by 24% and appetite for calorie-dense, high-carbohydrate foods by 33% to 45%[19]. The 2025 advisory links poor sleep to increased hunger[16]. More in sleep, stress and appetite.
Enough protein
The 2025 advisory makes adequate protein a priority for people on these drugs, mainly to preserve muscle[16]. There’s no evidence that protein quiets food noise; I include it as part of eating enough. You can estimate your number with the protein calculator and read more in protein and muscle on GLP-1s.
Stress, mindfulness and therapy
The 2025 advisory suggests that referral for cognitive behavioral therapy or mindfulness-based stress reduction may be considered when stress is a factor[16]. For food cravings, a 2025 meta-analysis of 24 controlled studies with 1,920 adults found that mindfulness-based interventions modestly reduce how intense cravings are, but not how often they happen. The certainty of the evidence is low[20].
Fewer food cues in sight
If food noise is, as Hayashi proposes, a form of food cue reactivity[1], it makes sense to reduce those cues: the bag of nuts off your desk, the sweets in a cupboard instead of on the counter. That’s a practical idea of mine, not something tested in food noise studies.
To see when it shows up, log it for a few days in the symptom diary: the time, what you were doing, how long since you’d eaten and how you slept.
When food noise is something more
Thinking about food a lot isn’t a disorder, but loss of control over eating is the factor most strongly linked to frequent food noise[4]. According to MedlinePlus, in binge eating disorder a person regularly eats unusually large amounts of food and feels a loss of control. Among the things that may lead to it, MedlinePlus lists unhealthy dieting, such as skipping meals or not eating enough nutritious food. It’s treatable, with psychological and nutrition counseling[21].
The 2025 advisory calls for screening for eating disorders before starting a GLP-1. It acknowledges that the effects of these drugs on eating disorders aren’t well established and could, in theory, ease or worsen symptoms[16].
When to talk to a professional
General guidance, not a diagnosis:
| Sign | What it may mean | What to do |
|---|---|---|
| You eat a large amount in a short time (for example, within 2 hours), can’t stop, and feel guilt or shame afterward | Possible binge eating, according to MedlinePlus[21] | Talk to your doctor; there’s treatment |
| You eat in secret, when you’re not hungry or until you’re uncomfortably full | Other symptoms MedlinePlus lists[21] | Get professional help |
| Thoughts about food distress you, keep you from concentrating or lead you to skip meals to “make up” for eating | Distress is what separates food noise from ordinary food thoughts, according to the 2025 panel[2] | Talk to your doctor or a psychologist |
| You’re on a GLP-1 and have or have had an eating disorder | The 2025 advisory calls for specialist assessment[16] | Tell the person who prescribes it |
| The noise hasn’t changed after months of treatment | Response varies from person to person | Bring it up using the doctor visit checklist; any change to treatment is the prescriber’s call |
The goal is to eat well and calmly, not to eat as little as possible.
Frequently asked questions
What is food noise?
An informal term, not a diagnosis, for thoughts about food that won’t switch off[1]. Under the 2025 definition, they’re persistent and the person finds them unwanted or distressing[2]. It’s measured with a five-item questionnaire, the FNQ[3].
Why am I constantly thinking about food?
Food noise studies haven’t untangled the causes yet. In related research, short sleep raised hunger in a small trial[19], and long gaps without meals leave you overly hungry[16]. If it comes with binges or loss of control, it’s worth seeing a professional[21].
Does Ozempic get rid of food noise?
No placebo-controlled trial has measured it with the FNQ. The EU label for Wegovy, the same semaglutide as Ozempic, reports fewer and less intense cravings[10], and the only direct measurement is a retrospective survey commissioned by the manufacturer[15]. It points to an average drop, without saying how much or for whom.
Does food noise come back after stopping Zepbound or Ozempic?
No one has measured it. Weight has been: in SURMOUNT-4, people who stopped tirzepatide gained an average of 14.0% over 52 weeks[18], and after stopping semaglutide, about two-thirds of the lost weight came back within a year[17]. My assumption is that if appetite returns, some of the noise does too.
How do you quiet food noise without medication?
No method has been proven against food noise itself. For hunger or cravings, there’s some support for regular meals[16], enough sleep[19] and, with low certainty, mindfulness for craving intensity[20]. If it distresses you or you lose control around food, get professional help[21].
Sources
Sources consulted for this article, with the access date.
- Other sourceNutrients (MDPI).Hayashi D, Edwards C, Emond JA, et al. What Is Food Noise? A Conceptual Model of Food Cue Reactivity. Nutrients. 2023;15(22):4809. doi:10.3390/nu15224809.accessed .
- Other sourceNutrition & Diabetes (Springer Nature).Dhurandhar EJ, Maki KC, Dhurandhar NV, et al. Food noise: definition, measurement, and future research directions. Nutr Diabetes. 2025;15:30. doi:10.1038/s41387-025-00382-x.accessed .
- Other sourceObesity (The Obesity Society, Wiley).Diktas HE, Cardel MI, Foster GD, et al. Development and validation of the Food Noise Questionnaire. Obesity (Silver Spring). 2025;33(2):289-297. doi:10.1002/oby.24216.accessed .
- Other sourceObesity Science & Practice (Wiley).Hayashi D, Masterson TD. Prevalence and Correlates of Perceived Food Noise Among U.S. Adults in a Nationally Representative Sample. Obes Sci Pract. 2026;12(5):e70201. doi:10.1002/osp4.70201.accessed .
- Other sourcePhysiology & Behavior.Lowe MR, Butryn ML. Hedonic hunger: a new dimension of appetite? Physiol Behav. 2007;91(4):432-439. doi:10.1016/j.physbeh.2007.04.006.accessed .
- Other sourceAppetite.Lowe MR, Butryn ML, Didie ER, et al. The Power of Food Scale. A new measure of the psychological influence of the food environment. Appetite. 2009;53(1):114-118. doi:10.1016/j.appet.2009.05.016.accessed .
- Other sourceFrontiers in Psychology.Meule A, Hermann T, Kübler A. A short version of the Food Cravings Questionnaire-Trait: the FCQ-T-reduced. Front Psychol. 2014;5:190. doi:10.3389/fpsyg.2014.00190.accessed .
- Drug labelU.S. Food and Drug Administration label, via DailyMed (National Library of Medicine).Wegovy (semaglutide) injection and tablets: US Prescribing Information (sections 12.1 and 12.2), revised 6/2026.accessed .
- Drug labelU.S. Food and Drug Administration label, via DailyMed (National Library of Medicine).Zepbound (tirzepatide) injection: US Prescribing Information (sections 12.1 and 12.2), revised 8/2026.accessed .
- Drug labelEuropean Medicines Agency (EMA).Wegovy (semaglutide): EU Summary of Product Characteristics, section 5.1.accessed .
- Drug labelEuropean Medicines Agency (EMA).Mounjaro (tirzepatide): EU Summary of Product Characteristics, section 5.1.accessed .
- Clinical trialDiabetes, Obesity and Metabolism.Blundell J, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242-1251. doi:10.1111/dom.12932.accessed .
- Clinical trialObesity (The Obesity Society, Wiley).Wharton S, et al. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023;31(3):703-715. doi:10.1002/oby.23673.accessed .
- Clinical trialInternational Journal of Obesity.Tronieri JS, Wadden TA, Walsh O, et al. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes (Lond). 2020;44(2):353-361. doi:10.1038/s41366-019-0348-6.accessed .
- Other sourceAdvances in Therapy (Springer).Arnaut T, et al. Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey. Adv Ther. 2026;43(8):3649-3659. doi:10.1007/s12325-026-03636-x.accessed .
- Clinical guidelineObesity (The Obesity Society, Wiley).Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity. 2025;33(8):1475-1503. doi:10.1002/oby.24336.accessed .
- Clinical trialDiabetes, Obesity and Metabolism.Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. doi:10.1111/dom.14725.accessed .
- Clinical trialJAMA.Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38-48. doi:10.1001/jama.2023.24945.accessed .
- Clinical trialAnnals of Internal Medicine.Spiegel K, Tasali E, Penev P, Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. doi:10.7326/0003-4819-141-11-200412070-00008.accessed .
- Meta-analysisBMC Psychology.Allameh SA, Mokhtari Z, Hosseini E, Askari G. Effects of mindfulness-based interventions on food craving in adults: a systematic review and meta-analysis of controlled clinical trials. BMC Psychol. 2025;13(1):1022. doi:10.1186/s40359-025-03307-6.accessed .
- InstitutionMedlinePlus, U.S. National Library of Medicine (NIH).Binge eating disorder (Medical Encyclopedia, reviewed April 19, 2025).accessed .